Anti-GHRHR antibody (ab28692)

ab28692 has been referenced in 9 publications.

• Jaszberenyi M  et al. Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists. Proc Natl Acad Sci U S A 111:781-6 (2014). WB . PubMed: 24379381
• Qin YJ  et al. Antagonist of GH-releasing hormone receptors alleviates experimental ocular inflammation. Proc Natl Acad Sci U S A 111:18303-8 (2014). PubMed: 25489106
• Rick FG  et al. Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases. Proc Natl Acad Sci U S A 109:1655-60 (2012). WB ; Human . PubMed: 22307626
• Siejka A  et al. GHRH antagonist MZ-5-156 increases the expression of AMPK in A549 lung cancer cells. Cell Cycle 10:3714-8 (2011). PubMed: 22041656
• Siejka A  et al. Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells. Prostate 70:1087-93 (2010). WB ; Human . PubMed: 20232355
• Ludwig B  et al. Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets. Proc Natl Acad Sci U S A 107:12623-8 (2010). WB, IHC-P ; Human . PubMed: 20616039
• Bellyei S  et al. GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro. Cancer Lett 293:31-40 (2010). WB ; Human . PubMed: 20064686
• Barabutis N  et al. Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor. J Mol Endocrinol 44:127-34 (2010). WB ; Human . PubMed: 19897610
• Schulz S  et al. Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody. Eur J Cancer 42:2390-6 (2006). WB, IHC-P, ICC ; Human . PubMed: 16904887